Onychomycosis Treatment Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Onychomycosis Treatment Market Research
and Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Onychomycosis Treatment Market Research
Report The latest report by IMARC, titled
Onychomycosis Treatment Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 finds that the global
onychomycosis treatment market reached a value of
US 3.1 Billion in 2022. Onychomycosis is a
fungal infection that occurs in the fingernails
and toenails, resulting in discomfort,
discoloration, chronic pain, and disfigurement.
It is a common nail infection in patients with
athletes feet and is caused by various
organisms, such as dermatophytes, yeasts, and
non-dermatophyte molds. It is usually diagnosed
through oxygen and hydrogen (KOH) examination,
potassium, culture, and histopathological
examinations of nail clippings and nail biopsies
and is treated through laser therapy, drugs, and
photodynamic therapies. Request Free Sample
Report https//www.imarcgroup.com/onychomycosis-t
reatment-market/requestsample
4
Report Description and Highlights
Report Description

Global Onychomycosis Treatment Market
Trends The market is primarily driven by the
rising prevalence of chronic medical ailments,
such as onychomycosis, human immunodeficiency
virus (HIV), diabetes, and peripheral artery
disease (PAD) among the masses. In addition, the
development of water-soluble antifungal treatment
solutions that can be administered orally and aid
in preventing secondary bacterial infections and
the growth of fungus represents another major
growth-inducing factor. Besides this,
onychomycosis is highly prevalent among
millennials and adults due to the increased
exposure to public swimming pools and utilization
of tight, contaminated, or soiled clothes, shoes,
and socks. This, coupled with the rising
popularity of topical nail lacquers and ointments
to maintain nail hygiene, is contributing to the
market growth. Moreover, the developing
healthcare infrastructure across the globe is
also creating a favorable market outlook. Looking
forward, IMARC Group expects the market to reach
US 4.3 Billion by 2028, exhibiting a CAGR of
5.37 during the forecast (2023-2028). Looking
forward, the market value is projected to reach a
strong growth during the forecast period
(2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Disease Type
Distal Subungual Onychomycosis
Proximal Subungual Onychomycosis
White Superficial Onychomycosis
Candidal Onychomycosis
Others Breakup by Treatment Type
Laser Therapy Photodynamic Therapy
Drug Treatment Breakup by Drug Class
Allylamine Azole Gris
eofulvin Others

6
Report Description and Highlights
Report Description
Breakup by Distribution Channel
Hospitals and Clinics Online Stores
Retail Pharmacies Others Breakup
by Region North America
United States Canada
Asia-Pacific China
Japan India
South Korea Australia
Indonesia Others
Europe

7
Report Description and Highlights
Report Description
Germany France
United Kingdom
Italy Spain
Russia Others Latin Am
erica Brazil M
exico Others Middle Ea
st and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• Bausch Health Companies Inc
• Cipla Limited Dr. Reddy's Laboratories Galderma S
  A GlaxoSmithKline PLC Kaken Pharmaceutical Co. Ltd
  Lumenis Ltd Moberg Pharma AB Novartis AG Pfizer
  Inc. The OTC Lab B.V
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/onychomycosis-treatment
  -market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us